DNA methylation analysis validates organoids as a viable model for studying human intestinal aging.
The epithelia of the intestine and colon turn over rapidly and are maintained by adult stem cells at the base of crypts. While the small intestine and colon have distinct, well-characterized physiological functions, it remains unclear if there are fundamental regional differences in stem cell behavior or region-dependent degenerative changes during aging. Mesenchyme-free organoids provide useful tools for investigating intestinal stem cell biology in vitro and have started to be utilized for investigating age-related changes in stem cell function. However, it is unknown whether organoids maintain hallmarks of age in the absence of an aging niche. Here we test whether stem cell enriched organoids preserve the DNA methylation-based aging profiles associated with the tissues and crypts from which they were derived. To address this, we use standard human methylation arrays and the human 'epigenetic clock' as a biomarker of age to analyze in vitro-derived, three-dimensional, stem cell-enriched intestinal organoids. We find that human stem cell-enriched organoids maintain segmental differences in methylation patterns and that age, as measured by the epigenetic clock, is also maintained in vitro. Surprisingly, we find that stem cell-enriched organoids derived from the small intestine exhibit striking epigenetic age reduction, relative to organoids derived from colon. Our data validate the use of organoids as a model for studying human intestinal aging and introduce methods that can be used when modeling aging or age-onset diseases in vitro.